or Try an Advanced Search...

    Technical Analysis for DERM - Journey Medical Corporation

    Grade Last Price % Change Price Change
    D 5.16 1.57% 0.08
    DERM closed up 1.57 percent on Friday, November 15, 2024, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical DERM trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 1.57%
    Doji - Bullish? Reversal 1.57%
    Stochastic Reached Oversold Weakness 1.57%
    Down 3 Days in a Row Weakness 1.57%
    Down 4 Days in a Row Weakness 1.57%
    Down 5 Days in a Row Weakness 1.57%
    Older End-of-Day Signals for DERM ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 21 hours ago
    Rose Above Previous Day's High 1 day ago
    Up 3% 1 day ago
    Up 2% 1 day ago
    Up 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DERM Chart by TradingView
    Basic chart:

    Profile

    Journey Medical Corporation (“Journey Medical”) is a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The Journey Medical team is comprised of industry experts with extensive experience commercializing some of the most successful prescription dermatology brands. Journey Medical is located in Scottsdale, Arizona and is a subsidiary of Fortress Biotech, Inc. (NASDAQ: FBIO).
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Health Care Pharmaceutical Products Dermatology

    Is DERM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Despite Journey Medical's Pullback, Insiders Still Gained US$118k
    Nov 13 Journey Medical GAAP EPS of -$0.12 beats by $0.03, revenue of $14.63M beats by $0.24M
    Nov 12 Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates
    Nov 12 Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
    Nov 5 FDA approves Journey Medical’s rosacea treatment Emrosi
    Nov 4 Journey gets FDA okay for Emrosi, releases preliminary Q3 earnings report
    Nov 4 Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?
    Nov 4 Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
    Oct 25 Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
    Oct 17 SWK Holdings Provides Portfolio Update
    See more DERM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.095
    52 Week Low 2.85
    Average Volume 98,881
    200-Day Moving Average 4.70
    50-Day Moving Average 5.62
    20-Day Moving Average 5.64
    10-Day Moving Average 5.38
    Average True Range 0.43
    RSI (14) 41.52
    ADX 16.85
    +DI 17.25
    -DI 20.50
    Chandelier Exit (Long, 3 ATRs) 5.39
    Chandelier Exit (Short, 3 ATRs) 6.30
    Upper Bollinger Bands 6.34
    Lower Bollinger Band 4.94
    Percent B (%b) 0.16
    BandWidth 24.84
    MACD Line -0.14
    MACD Signal Line -0.06
    MACD Histogram -0.0776
    Fundamentals Value
    Market Cap 64.54 Million
    Num Shares 12.5 Million
    EPS -0.69
    Price-to-Earnings (P/E) Ratio -7.48
    Price-to-Sales 1.15
    Price-to-Book 5.06
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.48
    Resistance 3 (R3) 5.47 5.36 5.42
    Resistance 2 (R2) 5.36 5.28 5.36 5.40
    Resistance 1 (R1) 5.26 5.23 5.31 5.27 5.39
    Pivot Point 5.15 5.15 5.18 5.15 5.15
    Support 1 (S1) 5.05 5.07 5.10 5.06 4.93
    Support 2 (S2) 4.94 5.02 4.94 4.92
    Support 3 (S3) 4.84 4.94 4.90
    Support 4 (S4) 4.85